3
Announcements
Trials
Browse
Landscape
Phase
Phase 1
1
Status
Completed
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Conditions
Carcinoma, Renal Cell
15
Melanoma
12
HIV Infections
6
Acquired Immunodeficiency Syndrome
6
Sarcoma, Kaposi
5
Lymphoma
3
Leukemia, Myelogenous, Chronic, BCR-ABL Positive
3
Triple Negative Breast Neoplasms
2
Precursor Cell Lymphoblastic Leukemia-Lymphoma
2
Multiple Myeloma
2
Leukemia, Myeloid, Chronic-Phase
2
Leukemia
2
Kidney Neoplasms
2
Hematologic Neoplasms
2
Uveal Melanoma
1
Uterine Cervical Dysplasia
1
Urinary Bladder Neoplasms
1
Urethral Neoplasms
1
Tumor Virus Infections
1
Thrombocythemia, Essential
1
Solid Cancers
1
Skin Neoplasms
1
Sarcoma
1
Polycythemia Vera
1
Peritoneal Neoplasms
1
Papillomavirus Infections
1
Pancreatic Neoplasms
1
Ovarian Neoplasms
1
Osteosarcoma
1
Neoplasm Metastasis
1
Interventions
Vinorelbine
1
Interferon alpha-2
1
Cyclophosphamide
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Completed
×
Advanced Neoplasm
×
Interferon alpha-2
×
Clear all
NCT00908869
2012-01-30
METRO1
Institut Paoli-Calmettes
Phase 1
Completed
30 enrolled